Ahmad I, Mui E, Galbraith L, Patel R, Tan E, Salji M, et al
. Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer. Proc Natl Acad Sci U S A. 2016;113:8290-5 pubmed publisher
..These data suggest that CaP patients could be stratified in terms of PPARG/FASN and PTEN levels to identify patients with aggressive CaP who may respond favorably to PPARG/FASN inhibition. ..
Galbraith L, Leung H, Ahmad I. Lipid pathway deregulation in advanced prostate cancer. Pharmacol Res. 2018;131:177-184 pubmed publisher
..g. FASN and CPT1), or in combination with AR pathway inhibitors (SCD1 and AR). ..